GenHealth.ai
Use Cases
Products
Company
Research
Get a Demo
See how we Automate Prior Authorization
Use our Population Health Analytics Co-pilot
Search all medical codes
T42.2X5S
Adverse effect of succinimides and oxazolidinediones, sequela
ICD10CM code
Similar Codes
ICD10CM codes
T42.2X5S
- Adverse effect of succinimides and oxazolidinediones, sequela
T42.2X5
- Adverse effect of succinimides and oxazolidinediones
T42.2X6S
- Underdosing of succinimides and oxazolidinediones, sequela
T42.2X5D
- Adverse effect of succinimides and oxazolidinediones, subsequent encounter
T42.2X5A
- Adverse effect of succinimides and oxazolidinediones, initial encounter
T42.2X1S
- Poisoning by succinimides and oxazolidinediones, accidental (unintentional), sequela
T42.2X4S
- Poisoning by succinimides and oxazolidinediones, undetermined, sequela
T42.2X3S
- Poisoning by succinimides and oxazolidinediones, assault, sequela
T42.2X2S
- Poisoning by succinimides and oxazolidinediones, intentional self-harm, sequela
T42.2X
- Poisoning by, adverse effect of and underdosing of succinimides and oxazolidinediones
HCPCS codes
G8494
- All quality actions for the applicable measures in the diabetes mellitus (dm) measures group have be
G0246
- Follow-up physician evaluation and management of a diabetic patient with diabetic sensory neuropathy
G8506
- Patient receiving angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb
G8485
- I intend to report the diabetes mellitus (dm) measures group
G8935
- Clinician prescribed angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (
J0330
- Injection, succinylcholine chloride, up to 20 mg
G8473
- Angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) therapy prescrib
G0245
- Initial physician evaluation and management of a diabetic patient with diabetic sensory neuropathy r
S9455
- Diabetic management program, group session
S9141
- Diabetic management program, follow-up visit to md provider
CPT4 codes
5010F
- Findings of dilated macular or fundus exam communicated to the physician or other qualified health c
86337
- Insulin antibodies
80168
- Ethosuximide
82943
- Glucagon
80161
- Carbamazepine; -10,11-epoxide
4328F
- Patient (or caregiver) queried about sleep disturbances (Prkns)
60699
- Unlisted procedure, endocrine system
80203
- Zonisamide
85305
- Clotting inhibitors or anticoagulants; protein S, total
3085F
- Suicide risk assessed (MDD, MDD ADOL)
Choose how you'd like to learn more
Email
Send us a message or questions and we can share more details.
Name
Email
Message
Company Name
Submit
Meet
Setup a calendar meeting with us; find a time now.
DIY Demo
Sign up for a free account to see our product in action.
Demo Gen AI Healthcare Analytics